Plasma lipoprotein (a), homocysteine, and other cardiovascular disease (CVD) risk factors in Nigerians with CVD

Ebesunun, M.O.; Agbedana, E.O.; Taylor, G.O.L.; Oladapo, O.O.
April 2008
Applied Physiology, Nutrition & Metabolism;Apr2008, Vol. 33 Issue 2, p282
Academic Journal
Elevated plasma lipoprotein (a) (Lp(a)) and total homocysteine (tHcy) concentrations, as well as fat distributions, are associated with cardiovascular disease (CVD) risk. The purpose of this study was to evaluate plasma Lp(a), tHcy, percentage body fat, anthropometric indices, and blood pressure (BP) and their relationships with each other in well-defined, hospital-based, CVD patients in a Nigerian African community. One hundred seventy patients suffering from hypertensive heart disease, hypertension, ischaemic heart disease, and myocardial infraction with the mean age of 45.3 ± 1.3 years and 58 apparently healthy volunteers with the mean age of 44.8 ±1.2 years were selected. Anthropometric indices and BP were measured. Percentage body fat, body mass index, and waist-to-hip ratio (WHR) were calculated. Plasma Lp(a) and tHcy concentrations were determined. The results showed significant increases in BP, skinfold thickness (SFT) variables, and WHR in all of the CVD patients. Plasma Lp(a) was also significantly increased (p < 0.001), whereas the slight increase in the mean tHcy was not statistically significant. Positive significant correlations were found between systolic BP, triceps, SFT, and percentage body fat (p < 0.01), whereas significant correlations were found between some body composition variables, tHcy, and systolic BP (p < 0.05). Our findings provide supportive evidence for altered plasma Lp(a) concentration in addition to some other traditional CVD risk factors in Nigerians. The role of homocysteine is not well defined.


Related Articles

  • Triglycerides and Cardiovascular Risk. Harchaoui, K. E. L.; Visser, M. E.; Kastelein, J. J. P.; Stroes, E. S.; Dallinga-Thie, G. M. // Current Cardiology Reviews;2009, Vol. 5 Issue 3, p216 

    In 1996 a meta-analysis was published showing that an increase in plasma triglyceride (TG) levels was associated with an increase in CHD risk, even after adjustment for high density lipoprotein cholesterol (HDL-C) levels. Very recently, two studies were published that further extent the early...

  • LDL Targets.  // Mayo Clinic Women's Health Source;Mar2007, Vol. 11 Issue 3, p2 

    The article provides information on the recommended low-density lipoprotein (LDL) cholesterol level. Optimal LDL targets depend on one's risk of heart diseases. LDL level should be less than 100 milligrams of cholesterol per deciliter of blood to consider it optimal. For people with known...

  • Ergo-Anthropometrics: Joining Fit to Fat to Predict Cardiovascular Risk. Morales, Alberto // MEDICC Review;Apr2011, Vol. 13 Issue 2, p52 

    In this article, the author discusses the need for a comprehensive anthropometric method that incorporates physical activity levels to detect obesity and predict the risk of coronary heart disease (CHD). He mentions several methods of anthropometry including body mass index (BMI), waist...

  • High levels of lipoprotein(a) can identify heart disease risk.  // Modern Medicine;Dec96, Vol. 64 Issue 12, p51 

    Outlines the study `Elevated Plasma Lipoprotein(a) and Coronary Heart Disease in Men Aged 55 Years and Younger: A Prospective Study,' by A.G. Bostom and colleagues, published in the August 21, 1996 issue of `JAMA.' High level of plasma lipoprotein(a) as an independent risk factor for premature...

  • Beyond cholesterol. Kluger, Jeffrey; Bjerklie, David // Time International (South Pacific Edition);08/04/97, Issue 31, p63 

    Informs of the possible role of homocysteine in heart disease mortality. The correlation between high homocysteine level and coronary disease mortality, according to a study in the `New England Journal of Medicine'; what is needed to prevent excessive homocysteine; What homocysteine is and what...

  • Beyond cholesterol. Kluger, Jeffrey; Bjerklie, David // Time;8/4/1997, Vol. 150 Issue 5, p48 

    Informs of the possible role of homocysteine in heart disease mortality. The correlation between high homocysteine levels and coronary disease mortality, according to a study in the `New England Journal of Medicine'; What is needed to prevent excessive homocysteine; What homocysteine is and...

  • The heart attackers. Cowley, Geoffrey; Springen, Karen // Newsweek;8/11/1997, Vol. 130 Issue 6, p54 

    Reports on studies indicating that an amino acid called homocysteine plays a critical role in destroying the arteries in humans. Arterial disease as beginning with an injury to the lining of the artery; Progression of the disease; Usefulness of homocysteine in the human body; How smoking and...

  • Sugar Belly: How Much is Too Much Sugar? Lim, Dennis // Nutrition Action Health Letter;Apr2012, Vol. 39 Issue 3, p1 

    The article discusses a study which notes that fructose in most added sugars is more likely to migrate to the belly. It cites a study by researchers in 2009 which found an increase in visceral fat in people who were fed with fructose. It cites concerns on the worldwide pandemic of obesity and...

  • Homocysteine and coronary heart disease in the Caerphilly cohort: a 10 year follow up Fallon, U B; Ben-Shlomo, Y; Elwood, P; Ubbink, J B; Smith, G Davey // Heart;Feb2001, Vol. 85 Issue 2, p153 

    The article discusses a study on the influence homocysteine concentration in the prevalence of coronary heart disease. The study examined the relationship between the disease and the concentration of homocysteine in the Caerphilly cohort. The study used a case-control method to determine such...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics